- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07682909
oneKNEE - Prospective, Non-interventional, Multicenter PMCF-Study (oneKNEE)
oneKNEE - Prospective, Non-interventional, Multicenter Post-Market Clinical Follow-Up Study
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Safety and Clinical Performance will be observed:
Safety: All adverse device effects: serious and non-serious adverse events with relation to either the product or the surgical procedure.
Clinical Performance: Difference in Oxford Knee Score (OKS) 2 years after implantation compared to preoperative state.
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Heike Oberascher
- Numéro de téléphone: +49 7461 95
- E-mail: studies@aesculap.de
Sauvegarde des contacts de l'étude
- Nom: Stefan Maenz, Dr.
- Numéro de téléphone: +49 7461 95
- E-mail: studies@aesculap.de
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Patient age ≤ 80 years
- Indication for a total knee replacement with one of the variants
- Written informed consent
- Willingness and mental ability to participate at the long-term follow-up examinations
Exclusion Criteria:
- Contraindications acc. to the Instructions for Use (IFU)
- Patient age < 18 years
- Known pregnancy
- BMI > 40
- Secondary gonarthrosis (e.g. rheumatoid arthritis, post-traumatic)
- Patients classified as high risk (ASA class >3)
- Patients with immunodeficiency, i.e. patients currently receiving immunosuppressive therapy or patients with severe immunodeficiency requiring drug therapy
- Preoperative: aHKA > 190° or aHKA < 170°
- Preoperative: aHKA > 190° or aHKA < 170°[KB1.1][HO1.2][KB1.3][HO1.4]
- Patients held in a custodial setting und - Patients in a relationship of dependence on the sponsor, the clinic or the investigator
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Safety of the implant
Délai: 2 years after implantation
|
Safety in terms of clinical outcome of oneKNEE® All adverse device effects: serious and non-serious adverse events with relation to either the product or the surgical procedure.
|
2 years after implantation
|
|
Clinical Performance in terms of clinical outcome of oneKNEE®
Délai: 2 years after implantation
|
Clinical Performance in terms of clinical outcome of oneKNEE®. Difference in Oxford Knee Score (OKS) 2 years after implantation compared to preoperative state. The Oxford Knee Score (OKS) is a validated joint-specific patient-reported outcome measure that is commonly employed to assess the outcome of TKA. It is a 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing TKA. It is short, reproducible, valid and sensitive to clinically important changes over time. OKS ranges from 0 to 48 with 48 being the best outcome. |
2 years after implantation
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Intraoperative complications
Délai: day of surgery
|
day of surgery
|
|
|
Optional: OrthoPilot® Data
Délai: Day of surgery
|
During surgery all data measured and stored by OrthoPilot® the computer assistant (e.g.
time needed for the surgery, alignment of all implant components) will be evaluated.
|
Day of surgery
|
|
Clinical Outcome by evaluating the Oxford Knee Score
Délai: V4=3 months post OP, V5= 1year p.OP, V6= 2years p.OP, V7= 5years p.OP
|
The Oxford Knee Score, OKS is a validated joint-specific patient-reported outcome measure that is commonly employed to assess the outcome of TKA.
It is a 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing TKA.
It is short, reproducible, valid and sensitive to clinically important changes over time.
OKS ranges from 0 to 48 with 48 being the best outcome.
|
V4=3 months post OP, V5= 1year p.OP, V6= 2years p.OP, V7= 5years p.OP
|
|
Evaluation of Changes in Quality of Life
Délai: V1= pre OP, V3= Discharge, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,
|
The EQ-5D-5L is a standardized instrument used to measure health outcomes. Developed by the EuroQol Group (EQ), it assesses five dimensions (5D) of health: Mobility Self-care Usual activities Pain/discomfort Anxiety/depression Each dimension has five levels (5L) of severity: no problems, slight problems, moderate problems, severe problems, and extreme problems |
V1= pre OP, V3= Discharge, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,
|
|
Evaluation of Patient Satisfaction by using PROMS: FJS
Délai: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
Forgotten Joint Score (FJS) : A joint-specific questionnaire with the aim to measure PRO of joint disorders . FJS is designed to measure the ability of the patient to "forget" about their problematic joint after treatment. Scale:
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Knee functional outcome
Délai: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
Range of Motion (ROM)
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Knee alignment, measurement of LDFA: Lateral distal femoral angle
Délai: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
LDFA: Lateral distal femoral angle.
The angle between the mechanical axis of the femur and the knee joint line.
Normal values typically range between 85° and 90° Medial proximal tibial angle (MPTA) and lateral distal femoral angle.
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Knee alignment, measurement of MPTA: Medial proximal tibial angle
Délai: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
MPTA: Medial proximal tibial angle.
The angle between the mechanical axis of the tibia and the knee joint line.
Normal values also typically average around 87° ± 3°.
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Knee alignment, measurement of HKA: Hip Knee Angle
Délai: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
HKA: (Hip Knee Angle).
The mechanical angle between the center of the femoral head, the center of the knee, and the center of the ankle.
It represents the overall lower limb alignment (e.g., neutral, varus, or valgus)
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Radiologically relevant findings by using AI
Délai: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
"Image biopsy lab" is a Digital AI platform that supports physicians and healthcare professionals in transforming medical imaging data into diagnostic findings.
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Adverse events
Délai: until end of study, up to 5 years.
|
Serious and non-serious adverse events (SAE/AE)
|
until end of study, up to 5 years.
|
|
Device deficiencies assessed by Adverse Events
Délai: until end of study, up to 5 years
|
In any case of Adverse Events marked as "related to the product/device"
|
until end of study, up to 5 years
|
|
Survival of implant components
Délai: From V3=Discharge to V7= 5 years post OP
|
From V3=Discharge to V7= 5 years post OP
|
|
|
Anterior knee pain
Délai: V1= preoperatively, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,
|
Anterior knee pain is used to evaluate the performance of the implantation and the implant itself. Rating is classified according to the description of Waters and Bentley in four dimensions: 0 (no pain), I (Mild pain that does not intrude on daily activities), II (Moderate pain that is a nuisance; patient not considering further surgery), III (Severe pain; Patient considering further surgery). The scoring is according to Feller et al. 0, 5, 10 and 15 points, respectively. (Feller et al., J Bone Joint Surg Am. 2003 Feb;85(2):212-7). |
V1= preoperatively, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Anne Postler, PD Dr. med, Städt. Klinikum Dresden
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- AAG-O-H-25103
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .